Kaylie Tram
Physician Assistant · Charlotte, NCNPI 1346842853
Payments from drug & device makers
Across 486 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$969
- Takeda Pharmaceuticals U.S.A., Inc.$698
- Axsome Therapeutics, Inc.$589
- Alkermes, Inc.$577
- plus $4K from 25 others
What the payments were for
- Food & beverage$8,52299%
- Education$961%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 66 | $1,113 |
| AbbVie | 57 | $1,018 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 59 | $969 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $698 |
| Axsome Therapeutics, Inc. | 29 | $589 |
| Alkermes, Inc. | 31 | $577 |
| Amgen(2 entities) | 36 | $574 |
| Johnson & Johnson(2 entities) | 25 | $570 |
| Neurocrine Biosciences, Inc. | 20 | $347 |
| Supernus Pharmaceuticals, Inc. | 17 | $272 |
| Lundbeck LLC | 14 | $256 |
| Corium, LLC | 12 | $232 |
| GSK | 9 | $156 |
| Teva Pharmaceuticals USA, Inc. | 9 | $154 |
| Neos Therapeutics, LP | 8 | $137 |
| Vanda Pharmaceuticals Inc. | 5 | $126 |
| AstraZeneca | 7 | $104 |
| E.r. Squibb & Sons, L.L.C. | 5 | $101 |
| Lilly USA, LLC | 4 | $84 |
| Ironshore Pharmaceuticals Inc. | 5 | $79 |
| UCB, Inc. | 4 | $74 |
| Collegium Pharmaceutical, Inc. | 3 | $74 |
| Tris Pharma Inc | 3 | $66 |
| Idorsia Pharmaceuticals US Inc | 4 | $63 |
| Novartis | 2 | $48 |
| Antares Pharma, Inc. | 2 | $35 |
| Avion Pharmaceuticals | 1 | $27 |
| Vertical Pharmaceuticals, LLC | 1 | $22 |
| Sanofi | 1 | $21 |
| Almatica Pharma LLC | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$121
How this compares
$8,618 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 15 | $1,552 |
| Mirtazapine | 18 | $407 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 23 | $352 |
| Trazodone Hcl | 14 | $231 |
| Fluoxetine Hcl | 15 | $178 |
| Buspirone Hcl | 13 | $163 |
| Lamotrigine | 34 | $137 |
| Duloxetine Hcl | 11 | $121 |
| Alprazolam | 22 | $114 |
| Clonazepam | 16 | $96 |
| Lorazepam | 21 | $89 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Charlotte
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Kristin CabedaCharlotte$135K
- Meghan EmigCharlotte$124K
- Juleidy TurnipseedCharlotte$84K
- Erin SiceloffCharlotte$50K
- Ronald RodriguezCharlotte$31K
- Lamiaa TolbaCharlotte$29K
- Sanaya GandhiCharlotte$29K
- Jacqueline LeyrerCharlotte$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.